-
21
Visual and High-Efficiency Secretion of SARS-CoV-2 Nanobodies with <i>Escherichia coli</i>
Published 2025-01-01Subjects: Get full text
Article -
22
A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies
Published 2024-12-01Subjects: “…Bispecific antibody…”
Get full text
Article -
23
A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer
Published 2024-12-01Subjects: Get full text
Article -
24
Facilitating high throughput bispecific antibody production and potential applications within biopharmaceutical discovery workflows
Published 2024-12-01Subjects: Get full text
Article -
25
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
Published 2024-12-01Subjects: Get full text
Article -
26
-
27
A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor-specificity
Published 2025-12-01Subjects: Get full text
Article -
28
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy
Published 2024-12-01Subjects: Get full text
Article -
29
Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1
Published 2024-12-01Subjects: “…Bispecific…”
Get full text
Article -
30
Characterization of the bispecific VHH antibody tarperprumig (ALXN1820) specific for properdin and designed for low-volume administration
Published 2024-12-01Subjects: “…Bispecific VHH antibody…”
Get full text
Article -
31
Anti-HER2 biparatopic antibody KJ015 has near-native structure, functional balanced high affinity, and synergistic efficacy with anti-PD-1 treatment in vivo
Published 2024-12-01Subjects: “…Bispecific antibody…”
Get full text
Article -
32
-
33
A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy
Published 2024-12-01Subjects: Get full text
Article -
34
Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces
Published 2024-12-01Subjects: Get full text
Article -
35
Elevated LIF and JAK-STAT activation drive severe COVID-19 in myeloma patients receiving the BCMA-CD3 bispecific antibody Elranatamab
Published 2025-01-01Subjects: Get full text
Article -
36
-
37
Six events that shaped antibody approvals in oncology
Published 2025-02-01Subjects: Get full text
Article -
38
Bispecific antibodies and CLEM: an analytical approach to advanced cell imaging for therapeutic strategies
Published 2025-01-01Subjects: “…Bispecific antibodies…”
Get full text
Article -
39
Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidity
Published 2025-12-01Subjects: “…Biparatopic bispecific antibody…”
Get full text
Article -
40
Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies
Published 2024-12-01Subjects: Get full text
Article